We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens Boots Alliance (WBA) Stock Moves -0.13%: What You Should Know
Read MoreHide Full Article
Walgreens Boots Alliance (WBA - Free Report) closed at $11.22 in the latest trading session, marking a -0.13% move from the prior day. The stock's change was more than the S&P 500's daily loss of 1.61%. At the same time, the Dow lost 1.91%, and the tech-heavy Nasdaq lost 1.41%.
Prior to today's trading, shares of the largest U.S. drugstore chain had gained 2.18% over the past month. This has lagged the Retail-Wholesale sector's gain of 11.89% and the S&P 500's gain of 12.65% in that time.
The upcoming earnings release of Walgreens Boots Alliance will be of great interest to investors. The company's upcoming EPS is projected at $0.34, signifying a 46.03% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $36.66 billion, up 0.85% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.66 per share and a revenue of $151.49 billion, representing changes of -42.36% and +2.59%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Walgreens Boots Alliance. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 0.88% higher. Right now, Walgreens Boots Alliance possesses a Zacks Rank of #3 (Hold).
In the context of valuation, Walgreens Boots Alliance is at present trading with a Forward P/E ratio of 6.76. This indicates a premium in contrast to its industry's Forward P/E of 5.19.
It is also worth noting that WBA currently has a PEG ratio of 1.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Retail - Pharmacies and Drug Stores industry was having an average PEG ratio of 0.78.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 2, which puts it in the top 1% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Walgreens Boots Alliance (WBA) Stock Moves -0.13%: What You Should Know
Walgreens Boots Alliance (WBA - Free Report) closed at $11.22 in the latest trading session, marking a -0.13% move from the prior day. The stock's change was more than the S&P 500's daily loss of 1.61%. At the same time, the Dow lost 1.91%, and the tech-heavy Nasdaq lost 1.41%.
Prior to today's trading, shares of the largest U.S. drugstore chain had gained 2.18% over the past month. This has lagged the Retail-Wholesale sector's gain of 11.89% and the S&P 500's gain of 12.65% in that time.
The upcoming earnings release of Walgreens Boots Alliance will be of great interest to investors. The company's upcoming EPS is projected at $0.34, signifying a 46.03% drop compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $36.66 billion, up 0.85% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.66 per share and a revenue of $151.49 billion, representing changes of -42.36% and +2.59%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Walgreens Boots Alliance. Such recent modifications usually signify the changing landscape of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection has moved 0.88% higher. Right now, Walgreens Boots Alliance possesses a Zacks Rank of #3 (Hold).
In the context of valuation, Walgreens Boots Alliance is at present trading with a Forward P/E ratio of 6.76. This indicates a premium in contrast to its industry's Forward P/E of 5.19.
It is also worth noting that WBA currently has a PEG ratio of 1.35. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Retail - Pharmacies and Drug Stores industry was having an average PEG ratio of 0.78.
The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 2, which puts it in the top 1% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.